SCI Abstract

Acute hepatitis E infection during chemotherapy for lung cancer: a case report

Acute hepatitis E infection during chemotherapy for lung cancer: a case report

Acute hepatitis E, one of the causes of acute liver injury, has been increasingly diagnosed in developed countries in rece...

Circulating Endothelial Cell Kinetic in Patients with Multiple Myeloma Who Receive Autologous Hematopoietic Stem Cell Transplantation

Circulating Endothelial Cell Kinetic in Patients with Multiple Myeloma Who Receive Autologous Hematopoietic Stem Cell Transplantation

<b><i>Introduction:</i></b> Neoangiogenesis has a crucial role in multiple myeloma (MM), and circu...

NEW TARGETED DRUGS FOR ACUTE MYELOID LEUKEMIA AND ANTIFUNGALS: PHARMACOKINETIC CHALLENGES AND OPPORTUNITIES

NEW TARGETED DRUGS FOR ACUTE MYELOID LEUKEMIA AND ANTIFUNGALS: PHARMACOKINETIC CHALLENGES AND OPPORTUNITIES

ABSTRACT Background Acute myeloid leukemia (AML) is a life-threatening disease whose treatment is made difficult by a numb...

A 7-day decitabine included conditioning regimen accelerated donor hematopoietic engraftment while reduced the occurrence of mucositis without interfering with prognosis

A 7-day decitabine included conditioning regimen accelerated donor hematopoietic engraftment while reduced the occurrence of mucositis without interfering with prognosis

Introduction: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the standard and curative treatment strate...

Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation)

Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation)

Introduction: Neoangiogenesis has a crucial role in Multiple Myeloma (MM) and Circulating Endothelial Cells (CECs) contrib...

Arrhythmia in Bruton Tyrosine Kinase Inhibitor treated patients: Unanswered Questions

Arrhythmia in Bruton Tyrosine Kinase Inhibitor treated patients: Unanswered Questions

(No abstract allowed for commentary)

Long Non-Coding RNA BCAR4 Promotes Oxaliplatin Resistance in Colorectal Cancer by Modulating miR-484-3p/RAB5C Expression

Long Non-Coding RNA BCAR4 Promotes Oxaliplatin Resistance in Colorectal Cancer by Modulating miR-484-3p/RAB5C Expression

<b><i>Background:</i></b> Oxaliplatin-based chemotherapy resistance is a major cause of recurrence...

Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant

Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant

<b><i>Background:</i></b> Allogeneic transplant is an effective salvage therapy in patients with H...

LncRNA BCAR4 promotes oxaliplatin resistance in colorectal cancer by modulating miR-484-3p/RAB5C expression

LncRNA BCAR4 promotes oxaliplatin resistance in colorectal cancer by modulating miR-484-3p/RAB5C expression

Background Oxaliplatin based chemotherapy resistance is a major cause of recurrence in patients with colorectal cancer (CR...

Evaluation of a novel combination therapy, based on trifluridine/tipiracil and fruquintinib, against colorectal cancer

Evaluation of a novel combination therapy, based on trifluridine/tipiracil and fruquintinib, against colorectal cancer

Introduction: Trifluridine/tipiracil hydrochloride (FTD/TPI, Lonsurf®) is an oral antineoplastic agent that has been ...